Novo Nordisk Warns of First Sales Drop Since Start of Ozempicnews2026-02-04T18:48:50+00:00February 4th, 2026|The New York Times|
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Tradingnews2026-01-16T18:05:15+00:00January 16th, 2026|The New York Times|
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Valuenews2025-11-21T21:25:40+00:00November 21st, 2025|The New York Times|
How Ozempic Maker Novo Nordisk Lost Its Shinenews2025-08-07T13:33:20+00:00August 7th, 2025|The New York Times|
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warningnews2025-07-29T17:51:03+00:00July 29th, 2025|The New York Times|
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugsnews2025-05-16T16:17:20+00:00May 16th, 2025|The New York Times|
S&P 500 and Nasdaq Stocks Post Modest Gains Amid Trump Tariff Uncertaintynews2025-04-15T15:17:41+00:00April 15th, 2025|The New York Times|
Dr. Oz: How His Millions Collide With Medicarenews2025-02-24T10:00:29+00:00February 24th, 2025|The New York Times|
Ramaswamy Has a High-Profile Perch and a Raft of Potential Conflictsnews2025-01-15T22:04:34+00:00January 15th, 2025|The New York Times|
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
